Max Bachmann
Corporate Officer/Principal at Dottikon Exclusive Synthesis AG
Network origin in Max Bachmann first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Dottikon Es Management AG
6
| Subsidiary | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Max Bachmann via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| DOTTIKON ES HOLDING AG | Chemicals: Specialty | Chief Executive Officer Director/Board Member Director/Board Member Director of Finance/CFO Human Resources Officer Corporate Officer/Principal Human Resources Officer Chief Tech/Sci/R&D Officer | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Chief Administrative Officer | |
| Dottikon Es America, Inc. | Director/Board Member Chief Executive Officer | ||
Systag System Technik AG
 Systag System Technik AG Medical SpecialtiesHealth Technology Systag System Technik AG specializes in laboratory automation. The private company is based in Ruschlikon, Switzerland. The Swiss company has been a leading partner for chemical and pharmaceutical production facilities worldwide since 1965. The CEO of the company is Marcel Haugg. | Medical Specialties | Chairman Director/Board Member | |
| Evolma Holding AG | Chairman Director/Board Member | ||
| Wematech AG | Human Resources Officer | ||
| 8stogg AG | Director/Board Member | ||
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Nextech III GP AG | Director/Board Member | ||
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Swiss Scientific Computing Center
 Swiss Scientific Computing Center Miscellaneous Commercial ServicesCommercial Services The Swiss Scientific Computing Center develops and provides supercomputing capabilities to solve important problems in science and society. The private company is based in Manno, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Nextech Venture Principals Ltd.
 Nextech Venture Principals Ltd. Financial ConglomeratesFinance Nextech Venture Principals Ltd. provides investment services. The private company is based in Jersey. | Financial Conglomerates | Director/Board Member | |
| Rising Tide Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
| Migros Verteilzentrum Suhr AG | Comptroller/Controller/Auditor | ||
| Wemedoo AG | Chairman | ||
Senn AG
 Senn AG SteelNon-Energy Minerals Senn AG manufactures steel products. It offers steel construction, metal construction, sheet metal work centre, stainless steel work centre, power generator sets, cranes and transportation and Mobil streets and areas services. The company is headquartered in Oftringen, Switzerland. | Steel | Human Resources Officer | |
| Nextech Holding AG | Chairman | ||
| University of Bern | College/University | Doctorate Degree | |
| UBS | Investment Managers | Corporate Officer/Principal | |
| University of Karlsruhe | College/University | Doctorate Degree | |
| University of California, Santa Barbara | College/University | Chief Tech/Sci/R&D Officer | |
| Mckinsey & Co., Inc. (Germany) | Corporate Officer/Principal | ||
| Aerzte Treuhand G Deragisch | Comptroller/Controller/Auditor | ||
| Kyoto University | College/University | Graduate Degree | |
scienceindustries
 scienceindustries Miscellaneous Commercial ServicesCommercial Services scienceindustries operates as Swiss Business Association Chemistry Pharma Life Sciences. The firm represents the economic and political interests of its member companies. It also promotes the global competitiveness of its member companies by promoting an innovation-friendly environment and providing services for its members. The company was founded on December 23, 1944 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Evide AG
 Evide AG Food: Specialty/CandyConsumer Non-Durables Evide AG engages in trading of goods in the agricultural sector. It specializes in dried fruit products. The company was founded in 2008 and is headquartered in Huenenberg, Switzerland. | Food: Specialty/Candy | Chairman | |
| frugan Holding AG | Chairman | ||
| Cultivport AG | Chairman | ||
| agrocult AG | Chairman | ||
| BACHEM HOLDING AG | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bachem Bioscience, Inc. | Chief Operating Officer | ||
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
Bachem Americas, Inc.
 Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Pharmaceuticals: Major | Chairman | |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Pharmaceuticals: Major | Chairman | |
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Medical/Nursing Services | Chairman | |
| Bachem Distribution Services Gmbh | Corporate Officer/Principal | ||
| Simplyscience Stiftung | Corporate Officer/Principal | ||
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Director/Board Member | |
| Bachem Japan KK | Chairman | ||
| Simply Science Foundation | Chairman | ||
| MFC Beteiligungs AG | Chairman | ||
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Investment Managers | Chief Executive Officer | |
| University of Basel | College/University | Doctorate Degree | |
Swiss Chemical Society
 Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
| Switzerland | 35 |
| United States | 9 |
| Germany | 5 |
| Japan | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 11 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 31 |
| Chairman | 19 |
| Corporate Officer/Principal | 17 |
| Chief Executive Officer | 7 |
| Doctorate Degree | 5 |
Most connected contacts
| Insiders | |
|---|---|
| Alfred Scheidegger | 20 |
| Thomas Früh | 17 |
| Markus Blocher | 10 |
| Marlene Born | 8 |
| Stephan Kirschbaum | 7 |
| Karin Krause | 5 |
| Emanuel Tschannen | 4 |
| Urs Brändli | 4 |
- Stock Market
- Insiders
- Max Bachmann
- Company connections
